Delivery Order SPE2DB20D2014-SPE2DB25FD17Y
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $23,293.20 delivery order on August 22, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is to be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a discrete fulfillment under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, with a contract ceiling value of $14,125.92 and an ultimate completion date of July 21, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a standard pharmaceutical procurement supporting federal medical supply chain requirements. The place of performance is listed as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Epinephrine 0.3 mg auto-injector (2-pack) with a ceiling value of $7,298.97. This firm fixed-price delivery order, with an ultimate completion date of September 29, 2025, represents a competitively awarded, non-set-aside contract with no small business designation. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location, where the...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Epinephrine 0.3 mg auto-injector packs valued at $2,954.20. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of June 17, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a single delivery order issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs with a ceiling value of $3,401.68. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract will be performed in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs. This contract represents a firm fixed-price delivery order with a ceiling value of $3,057.33 and an ultimate completion date of August 15, 2025. The award was made through open competition with no set-aside designation. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, with a contract ceiling value of $1,533.52 and a completion date of September 18, 2025. This non-set-aside, firm fixed-price delivery order represents a routine pharmaceutical procurement under AmerisourceBergen's broader federal supply arrangement. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Epinephrine 0.3 mg auto-injector (2-pack) with a ceiling value of $2,418.48. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 29, 2025. The contract is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of epinephrine 0.3 mg auto-injector two-packs, with a ceiling value of $1,237.60. This competitively awarded, non-set-aside contract was executed on September 25, 2025, with an ultimate completion date of September 26, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The firm fixed-price delivery order represents a component of...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for epinephrine 0.3 mg auto-injector two-packs with a ceiling value of $1,249.56. This firm fixed-price delivery order, which was not set-aside and competitively awarded, was issued on September 18, 2025, with an ultimate completion date of September 19, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FD17YDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs with a ceiling value of $3,732.72. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract specifies a place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. AmerisourceBergen Drug Corp is one of the nation's largest pharmaceutical distributors and serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and running through December 2026. The parent IDC enables the company to supply a broad range of pharmaceutical products and medical supplies globally to support military healthcare programs and other federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The delivery order is scheduled for ultimate completion by September 30, 2025.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 9/29/25 |